|Bid||170.01 x 100|
|Ask||0.00 x 0|
|Day's range||219.92 - 221.42|
|52-week range||161.29 - 225.23|
|PE ratio (TTM)||63.80|
|Earnings date||31 Jan 2018 - 5 Feb 2018|
|Forward dividend & yield||2.92 (1.32%)|
|1y target est||240.31|
The Zacks Analyst Blog Highlights: Baxter International, BostonScientific, Intuitive Surgical and Becton and Dickinson
Considering Trump's growing focus on APAC, the region seems to be poised to yield accretive returns over the long term. Favorable MedTech trends in APAC hold promise.
New BD HealthSight™ Platform for Enterprise Medication Management Takes System-Wide Approach to Make Medication Management Safer, Simpler and Smarter FRANKLIN LAKES, N.J. , Nov. 16, 2017 /PRNewswire/ -- ...
"Today's announcement of our intent to divest two product lines is another step forward in the regulatory review process of BD's planned acquisition of Bard," said Vincent A. Forlenza, chairman and CEO of BD.
- As reported, full fiscal year revenues of $12.093 billion decreased 3.1 percent, which primarily reflects the divestiture of the Respiratory Solutions business. - On a comparable, currency-neutral basis, ...
"We continue to make good progress on the Bard acquisition and the conditional clearance from the European Commission is a positive step forward," said Vincent A. Forlenza, chairman and CEO of BD. "As expected, we have committed to divesting certain assets associated with our soft tissue core needle biopsy product line, which we acquired with CareFusion, to satisfy the conditions to closing requested by the European Commission.
FRANKLIN LAKES, N.J. , Oct. 5, 2017 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that it will conduct a live webcast of its fourth fiscal quarter and full fiscal year ...
FRANKLIN LAKES, N.J., Sept. 29, 2017 /PRNewswire/ -- BD (Becton, Dickinson and Company) (BDX), a leading global medical technology company, today announced that two current directors of C.R. Bard, Inc. will join the BD board of directors following the completion of BD's pending acquisition of Bard. Timothy M. Ring, chairman and CEO of Bard, and David F. Melcher, president and CEO of the Aerospace Industries Association, have been elected to the two newly created seats on the BD board of directors, in accordance with the acquisition agreement.
The Franklin Lakes, New Jersey-based company said it had a loss of 75 cents per share. Earnings, adjusted for non-recurring costs, came to $2.46 per share. The results topped Wall Street expectations. ...
On a per-share basis, the Franklin Lakes, New Jersey-based company said it had net income of $1.58. Earnings, adjusted for one-time gains and costs, were $2.30 per share. The results exceeded Wall Street ...
Jim Cramer says earnings and mergers, not Wednesday's tax announcement, are the real factors pushing the market higher.
On a per-share basis, the Franklin Lakes, New Jersey-based company said it had net income of $2.58. Earnings, adjusted for one-time gains and costs, came to $2.33 per share. The results beat Wall Street ...